MEDX vs. GSG
MEDX (Horizon Kinetics Medical ETF) and GSG (iShares S&P GSCI Commodity-Indexed Trust) are both exchange-traded funds - MEDX is a Health & Biotech Equities fund actively managed by Horizon, while GSG is a Commodities fund tracking the S&P GSCI Total Return Index. MEDX is actively managed, while GSG is passively managed. Over the past 3 years, MEDX returned 5.77%/yr vs 19.31%/yr for GSG. At a correlation of -0.06, they often move in opposite directions. MEDX charges 0.85%/yr vs 0.75%/yr for GSG.
Performance
MEDX vs. GSG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MEDX achieves a 0.84% return, which is significantly lower than GSG's 42.58% return.
MEDX
- 1D
- 0.92%
- 1M
- 2.85%
- YTD
- 0.84%
- 6M
- 0.03%
- 1Y
- 29.45%
- 3Y*
- 5.77%
- 5Y*
- —
- 10Y*
- —
GSG
- 1D
- 0.77%
- 1M
- -4.83%
- YTD
- 42.58%
- 6M
- 41.06%
- 1Y
- 51.52%
- 3Y*
- 19.31%
- 5Y*
- 15.74%
- 10Y*
- 7.69%
MEDX vs. GSG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MEDX Horizon Kinetics Medical ETF | 0.84% | 28.62% | -4.68% | -6.22% |
GSG iShares S&P GSCI Commodity-Indexed Trust | 42.58% | 5.93% | 8.52% | -5.42% |
Correlation
The correlation between MEDX and GSG is -0.24, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.10 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2023 | -0.06 |
The correlation between MEDX and GSG shifts across timeframes, from -0.24 (1 year) to -0.06 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MEDX vs. GSG — Risk / Return Rank
MEDX
GSG
MEDX vs. GSG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Horizon Kinetics Medical ETF (MEDX) and iShares S&P GSCI Commodity-Indexed Trust (GSG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MEDX | GSG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.60 | ||
| Sortino ratioReturn per unit of downside risk | -0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.40 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 2.81 | 5.47 | -2.67 |
| Martin ratioReturn relative to average drawdown | 7.81 | 14.39 | -6.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MEDX | GSG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.65 | 2.26 | -0.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.70 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.35 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | -0.09 | +0.35 |
Drawdowns
MEDX vs. GSG - Drawdown Comparison
The maximum MEDX drawdown since its inception was -23.10%, smaller than the maximum GSG drawdown of -89.62%. Use the drawdown chart below to compare losses from any high point for MEDX and GSG.
Loading charts...
Drawdown Indicators
| MEDX | GSG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.10% | -89.62% | +66.52% |
Max Drawdown (1Y)Largest decline over 1 year | -10.54% | -9.46% | -1.08% |
Max Drawdown (3Y)Largest decline over 3 years | -23.10% | -14.94% | -8.16% |
Max Drawdown (5Y)Largest decline over 5 years | — | -29.12% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.64% | — |
Current DrawdownCurrent decline from peak | -5.55% | -56.95% | +51.40% |
Average DrawdownAverage peak-to-trough decline | -6.72% | -63.71% | +56.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.78% | 3.59% | +0.19% |
Volatility
MEDX vs. GSG - Volatility Comparison
The current volatility for Horizon Kinetics Medical ETF (MEDX) is 4.92%, while iShares S&P GSCI Commodity-Indexed Trust (GSG) has a volatility of 7.65%. This indicates that MEDX experiences smaller price fluctuations and is considered to be less risky than GSG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MEDX | GSG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.92% | 7.65% | -2.73% |
Volatility (6M)Calculated over the trailing 6-month period | 13.08% | 20.42% | -7.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.88% | 22.95% | -5.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.97% | 22.61% | -5.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.97% | 22.03% | -5.06% |
MEDX vs. GSG - Expense Ratio Comparison
MEDX has a 0.85% expense ratio, which is higher than GSG's 0.75% expense ratio.
Dividends
MEDX vs. GSG - Dividend Comparison
MEDX's dividend yield for the trailing twelve months is around 1.22%, while GSG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
GSG iShares S&P GSCI Commodity-Indexed Trust | 0.00% | 0.00% | 0.00% | 0.00% |
MEDX Horizon Kinetics Medical ETF | 1.22% | 1.23% | 1.92% | 4.94% |
Frequently Asked Questions
MEDX and GSG have a correlation of -0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GSG has higher volatility (7.65%) compared to MEDX (4.92%). In terms of maximum drawdown, MEDX dropped -23.10% vs GSG's -89.62%.
On 3-year performance, GSG leads with 19.31% vs 5.77% for MEDX. On fees, GSG is cheaper at 0.75% per year. On volatility, MEDX has been the lower-risk option at 4.92%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, GSG has performed better with a 19.31% return vs 5.77%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GSG is cheaper with a 0.75% expense ratio, compared with 0.85% for MEDX.
MEDX has the higher dividend yield at 1.22%, compared with 0.00% for GSG.
MEDX is categorized as Health & Biotech Equities, while GSG is Commodities. They also come from different issuers: Horizon and iShares. Their fees differ too: 0.85% for MEDX and 0.75% for GSG.
GSG currently has the higher Sharpe Ratio (2.26 vs 1.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MEDX and GSG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer